SCHEMBL24915920

SCHEMBL24915920

CCc1cc(C(=O)NC)c2nc(C)cc(C(C)C)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.37
PLK1 P53350 1/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
SMN1; SMN2 Q16637 5/20 0.33
CD38 P28907 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TBK1 Q9UHD2 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 4/20 0.32
HTT P42858 3/20 0.32
MAPT P10636 2/20 0.32
PKM P14618 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HSP90AA1 P07900 2/20 0.32
HSP90AB1 P08238 1/20 0.32
GBA1 P04062 1/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915922 0.84 MEN1 (0.40) L3MBTL1MEN1KMT2AKDM4EALDH1A1
SCHEMBL24916059 0.84 POLB (0.41) L3MBTL1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL24915926 0.83 TLR9 (0.42) TLR8TLR7SMN1; SMN2KDM4EALDH1A1
SCHEMBL24915849 0.80 PLK1 (0.37) L3MBTL1PLK1SMN1; SMN2ALDH1A1HTT
SCHEMBL24915921 0.80 MTNR1A (0.43) PLK1SMN1; SMN2CD38MEN1KMT2A
SCHEMBL29924057 0.75 RAB9A (0.42) PLK1CD38MEN1KMT2AKDM4E
SCHEMBL24916053 0.72 DHFR (0.43) L3MBTL1KDM4EMAPT
SCHEMBL24916056 0.70 KDM4E (0.34) L3MBTL1KDM4EALDH1A1MAPTHSD17B10
SCHEMBL24915919 0.69 HPGD (0.43) L3MBTL1SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL29923860 0.66 PARP1 (0.49) PLK1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 L3MBTL1 1214/4885PLK1 264/4885TLR8 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.